|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-3-16
|
|
pubmed:abstractText |
Tamoxifen has been associated with an increased risk of stroke. There is, however, little information on the effect in the post-treatment period. Using data from the Swedish Breast Cancer Group adjuvant trial of 5 vs 2 years of tamoxifen treatment, we now report both short-term and long-term effects on morbidity as well as mortality because of cerebrovascular disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1532-1827
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
899-902
|
|
pubmed:dateRevised |
2011-5-13
|
|
pubmed:meshHeading |
pubmed-meshheading:21343938-Adult,
pubmed-meshheading:21343938-Aged,
pubmed-meshheading:21343938-Antineoplastic Agents, Hormonal,
pubmed-meshheading:21343938-Breast Neoplasms,
pubmed-meshheading:21343938-Carcinoma,
pubmed-meshheading:21343938-Cerebrovascular Disorders,
pubmed-meshheading:21343938-Chemotherapy, Adjuvant,
pubmed-meshheading:21343938-Comorbidity,
pubmed-meshheading:21343938-Female,
pubmed-meshheading:21343938-Follow-Up Studies,
pubmed-meshheading:21343938-Humans,
pubmed-meshheading:21343938-Middle Aged,
pubmed-meshheading:21343938-Randomized Controlled Trials as Topic,
pubmed-meshheading:21343938-Risk Factors,
pubmed-meshheading:21343938-Sweden,
pubmed-meshheading:21343938-Tamoxifen,
pubmed-meshheading:21343938-Time Factors
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial.
|
|
pubmed:affiliation |
Oncologic center, Linköping University Hospital, S-581 85 Linköping, Sweden. johan.rosell@lio.se
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|
